Estradiol(E2/E3) antibody/antigen (BSA/OVA/KLH conjugated hapten)

 Download 

anti-Estradiol(E2/E3) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Go to Hormones diagnostics products collection >>

Product information

Size： 1mg | 10mg | 100mg

Product Description

BSA-Estradiol(E2/E3)

OVA-Estradiol(E2/E3)

Anti-Estradiol(E2/E3) mouse monoclonal antibody

Anti-Estradiol(E2/E3) human monoclonal antibody

Reference

Validation Data

Click to get more Data / Case study about the product.

Biomarker Information

1. What is Estradiol (E2/E3), and what is its role in in vitro diagnosis?

Estradiol (E2/E3) stands as a quintessential member of the steroid hormone family, representing one of the primary forms of estrogen in both females and males. In females, Estradiol is predominantly synthesized by the ovaries, whereas in males, it emanates from the testes. This hormone exerts a profound influence over an array of physiological processes, with its most pronounced effects observed within the female reproductive system.

(Serial Number 1) In the realm of in vitro diagnosis, Estradiol (E2/E3) assumes a pivotal role as an invaluable biomarker, serving as a linchpin in numerous diagnostic applications. Its significance can be delineated across several domains:

Fertility Assessment: Estradiol levels are pivotal for the evaluation of female fertility. The precise measurement of Estradiol aids in gauging ovarian function, facilitating the prediction of ovulation timing, and monitoring the efficacy of fertility treatments, including the intricate processes of in vitro fertilization (IVF).

Menstrual Cycle Monitoring: Estradiol exhibits distinct patterns throughout the menstrual cycle, featuring notable variations during the follicular and luteal phases. Accurate monitoring of Estradiol fluctuations empowers individuals to comprehensively track their menstrual cycles, enabling informed family planning decisions and the early detection of cycle irregularities.

Hormone Replacement Therapy (HRT): Postmenopausal women undergoing hormone replacement therapy (HRT) rely on the precise measurement of Estradiol levels. Such measurements are instrumental in optimizing HRT, ensuring the alleviation of menopausal symptoms with minimal adverse effects.

Endocrine Disorder Diagnosis: Estradiol levels serve as a diagnostic beacon, illuminating the presence of various endocrine disorders. Conditions such as polycystic ovary syndrome (PCOS) and hormone-secreting tumors can be identified through Estradiol measurements, facilitating early diagnosis and the initiation of tailored therapeutic interventions.

Bone Health Evaluation: Estradiol plays a fundamental role in maintaining bone density, rendering it critical for assessing the risk of osteoporosis. Estradiol measurement forms a linchpin in evaluating bone health, allowing for the timely implementation of preventive measures.

Breast Cancer Risk Assessment: Estradiol levels are intricately linked to the risk of breast cancer. Regular Estradiol measurements provide invaluable insights into individual risk factors, guiding informed decisions regarding breast cancer screening and preventive measures.

2. Why measure Estradiol (E2/E3)?

(Serial Number 2) The measurement of Estradiol (E2/E3) emerges as a necessity rooted in a multitude of compelling reasons:

a. Reproductive Health: Given its indispensable role in the female reproductive system, Estradiol measurement is foundational to assessing and managing female fertility. Accurate measurement enables the comprehensive evaluation of ovarian function, prediction of ovulation, and effective management of fertility concerns.

b. Menstrual Cycle Insights: Estradiol monitoring provides individuals with the tools to gain comprehensive insights into their menstrual cycles. This knowledge empowers women to make informed family planning decisions and facilitates the early detection of cycle irregularities, which could be indicative of underlying health concerns.

c. Optimizing Hormone Therapy: For postmenopausal women embarking on hormone replacement therapy (HRT), precise Estradiol measurement is pivotal. It allows healthcare professionals to tailor HRT regimens to achieve optimal efficacy while minimizing potential side effects.

d. Early Disease Detection: Abnormal Estradiol levels can serve as early indicators of various health conditions, ranging from hormonal imbalances to reproductive disorders. Timely detection through Estradiol measurement facilitates early intervention and targeted treatment, mitigating potential health risks.

e. Risk Stratification: The intricate connection between Estradiol levels and breast cancer risk underscores the importance of regular measurement. By facilitating individualized risk assessment, Estradiol measurements inform decisions regarding breast cancer screening and preventive measures, thereby contributing to early cancer detection and improved outcomes.

In conclusion, the measurement of Estradiol (E2/E3) within the context of in vitro diagnosis represents an indispensable component of contemporary healthcare. It empowers individuals and healthcare professionals alike by providing insights into reproductive health, menstrual cycle dynamics, hormone therapy optimization, early disease detection, and personalized breast cancer risk assessment. Biopharmaceutical companies offering anti-Estradiol antibodies and small molecule competitive antigens play a pivotal role in enabling accurate and dependable Estradiol detection, thereby enhancing healthcare outcomes and promoting women's well-being.

About GDU